Paul Carter

2024-06-12T14:04:12+01:00

Meet The Team

Paul Carter

Paul Carter

Paul has 30+ years’ experience in both CRO and pharmaceutical industries (AstraZeneca) as a study director/study monitor on a range of studies, including all delivery routes and species but specialising as an inhalation toxicologist.  For the last 10 years at AstraZeneca, Paul led the global strategic implementation of preclinical outsourcing of inhalation toxicology studies.  A recognised international expert in the field of inhalation toxicology/aerosol science, Paul has been an active committee member of the Association of Inhalation Toxicologists since 1987. Paul is a versatile toxicologist within the pharmaceutical arena and has all round knowledge of all processes involved in drug research and development.

Sean Redmond

2024-06-12T14:40:19+01:00

Meet The Team

Sean Redmond

Sean Redmond

MSc

Sean is an experienced project toxicologist with more than 30 years of drug discovery and development experience gained in AstraZeneca, where he was formerly Senior Director of Oncology Safety.  He has led the safety assessment of multiple candidate drugs, delivering nonclinical strategies and bringing new molecules to clinical trial.  Sean has experience of working in the UK and US and specialises in oncology small molecules and nanomedicines.

Simon Craige

2025-06-23T14:12:44+01:00

Meet The Team

simon | ApconiX

Simon Craige

MSc, ERT, DABT, FRCPath

Simon has over 20 years’ nonclinical and toxicology experience working in contract research, medical and pharmaceutical organisations across multiple disciplines. These include small molecules, vaccines, biologics, and medical devices. He has experience of a diverse range of therapeutic areas (including oncology, CNS, ocular and dermal) and across various phases of drug discovery and development.

As well as a Master’s degree in toxicology from the University of Birmingham, professional credentials include European Registered Toxicologist (ERT) since 2012, American Board Registered Toxicologist (DABT) since 2014 and a Fellow of the Royal College of Pathologists in Toxicology (FRCPath) in 2025. He’s currently a member of the Society of Toxicology (SOT), American College of Toxicology (ACT), British Society of Toxicology (BTS) and European Teratology Society (ETS).

Read more here

Go to Top